CD274 and neuroblastoma: Rigo et al. have shown that monotherapy with anti-PD-1/PD-L1 mAbs was not effective on systemic NB progression in vivo in two syngeneic models of disseminated NB, generated by the injection of Neuro2a or NXS2 cells, which express PD-L1.